Emory University School of Medicine Department of Human Genetics
DIRECTORY | SCHOOL OF MEDICINE | EMORY UNIVERSITY | ΚΚΚ TEXT Emory University School of Medicine Department of Human Genetics Emory University School of Medicine Department of Human Genetics
Employee Login Username: Password:
  • Home
  • Research
  • Clinical
  • Education
  • Faculty
Genetic Clinics

Adult Genetics Clinics
Cancer Genetics Program
Down Syndrome Clinic
Fragile X Syndrome Clinic
General Genetics Clinic
Genetic Counseling
Jewish Genetic Disease Program
Lysosomal Storage Disease Center 
Newborn Screening
Metabolic Genetics and Nutrition Program
Pediatric Genetic Clinics 
Lysosomal Storage Disease Center
Home | Clinical Team | Appointments | Research & Clinical Trials
Gifts & Donations | Fabry Disease | LysoMan 
Meetings | Resources | Lab Testing |  Pompe Disease

Remembering Paul Fernhoff

LSDC "Ducks for Bucks" Race and Family Fun Day



Mission Statement: 
Emory's Lysosomal Storage Disease Center in Atlanta, Georgia provides diagnostic, evaluation, management, and treatment services for patients from all over the Southeastern United States.  The lysosomal storage diseases (LSDs) are a group of conditions in which certain substances or substrates build up in compartments of the body's cells called lysosomes. Lysosomes contain enzymes that allow cells to digest and recycle the body's substrates or macromolecules. LSDs are caused by missing or poorly functioning enzymes that are unable to perform their normal activities. Over time, excessive amounts of the substrates accumulate and cause damage to the involved systems and organs in thebody. In some cases, the diagnosis of a LSD is mistaken for another disorder. If you're a healthcare provider, please print our diagnostic information page:   

Lysosomal Storage Diseases:  Don't be caught missing this diagnosis


History of Emory's LSDC
When Emory's Lysosomal Storage Disease Center was founded in 1993, Type I Gaucher disease was the first and only genetic disorder that could be treated effectively with enzyme replacementtherapy (ERT). Since then, treatment has become available clinically for Fabry Disease and Mucopolysaccharidosis Type I (also known as Hurler, Hurler-Scheie, or Scheie syndrome), Mucopolysaccharidosis TypeII (also known as Hunter syndrome), Mucopolysaccharidosis Type VI (also known as Maroteaux-Lamy), and Pompe disease (also known as acid maltase deficiency or glycogen storage disease type II). A variety of treatment regimes including chaperone therapies, enzyme replacement therapy, and substrate inhibition therapy are currently under development for many LSDs.

Contact Us
The Emory Lysosomal Storage Disease Center is devoted to remaining on the cutting edge of research and treatment providing comprehensive and compassionate care for all of our patients affected by lysosomal storage diseases. To schedule an appointment or speak with a member of our lysosomal storage disease team, call 404-778-8565 or 800-200-1524.  

Check out our facebook page for center updates!

Emory Lysosomal Storage Disease Center
Emory University School of Medicine Department of Human Genetics
Learn more arrow

Emory University School of Medicine Department of Human Genetics
Learn more arrow

ad
Learn more arrow

Emory University School of Medicine Department of Human Genetics
Learn more arrow

News & Events Volunteer Careers Directions Contact Site Map Email
©2012 Emory University Department of Human Genetics